Found 18 matching trials
Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma PHASE1 This phase I/II trial studies the best dose and side effects of mogamulizum...
Show More Location
University of California Davis Comprehensive Cancer Center
Learn More & Join Trial
Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome PHASE1 Background:
Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Se...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides PHASE1 This phase Ib/II trial investigates the side effects of mogamulizumab and e...
Show More Location
Emory University Hospital
Learn More & Join Trial
Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors PHASE1 Mogamulizumab in Combination with MEDI4736 (Durvalumab) and Mogamulizumab i...
Show More Location
The Angeles Clinic
Learn More & Join Trial
Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment PHASE1 This phase Ib/II trial identifies the best dose and possible benefits and/o...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) EARLY_PHASE1 This is an open label, single arm, single-center, pilot study of concurrent...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) PHASE2 The purpose of this study is to estimate the overall response rate of subje...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma PHASE2 This phase II trial studies the effect of extracorporeal photopheresis (ECP...
Show More Learn More & Join Trial
A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors PHASE1 This study is a Phase 1b, open label, multi center, multi-dose trial design...
Show More Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
Mogamulizumab Q4week Dosing in Participants With R/R CTCL PHASE2 This is an open-label, multicenter, Phase 2 study to evaluate the safety an...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial